@carmen-tm.bsky.social, @malvarezdelvayo.bsky.social, @adrimaqueda.com and @maberalv.bsky.social revealed in their work that the the tool, for which the Basque health service paid €1.6M, was meant to hit 85% accuracy, but it misses 31% of melanomas — and it flags 1 in 5 benign moles as cancer.
